Post-Traumatic Stress Disorder and Other Mental Health Workers' Compensation Claims Arising During COVID-19
Veterans' Issues and How They May Impact Your Practice
We’ve previously highlighted psilocybin as an alternative treatment for various neuropsychiatric disorders, including anxiety, depression, and PTSD, along with legislative efforts at the state and federal levels to legalize...more
On December 12, 2023, the Multidisciplinary Association for Psychedelic Studies Public Benefit Corporation (“MAPS PBC”) announced it has submitted a new drug application (“NDA”) to the FDA for the use of...more
Earlier this month, Senators Brian Schatz (D-HI) and Cory Booker (D-NJ) sent a letter to the National Institutes of Health (NIH) and the Food and Drug Administration (FDA) urging both agencies to advance research on the...more
Functional MRI studies suggest that psychotherapy for PTSD improves symptoms by changing the way brain networks communicate with each other, offering a potential “biosignature” for effective treatment...more